Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 7, 2026

Growing Neural Stem Cells from Conventional and Nonconventional Regions of the Adult Rodent Brain
11:27

Growing Neural Stem Cells from Conventional and Nonconventional Regions of the Adult Rodent Brain

Published on: November 18, 2013

Developmental perspectives on human midbrain-derived neural stem cells.

Johannes Schwarz1

  • 1Department of Neurology, University of Leipzig, Leipzig, Germany. johannes@caltech.edu

Parkinsonism & Related Disorders
|November 19, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tackling gender in progressive supranuclear palsy: Male patients present more apathy.

Journal of Parkinson's disease·2025
Same author

A Short Cognitive and Neuropsychiatric Assessment Scale for Progressive Supranuclear Palsy.

Movement disorders clinical practice·2025
Same author

Air Leakages at Microvalves: Pressure Decay Measurements and Extended Continuum Modelling of Knudsen Flows.

Micromachines·2024
Same author

A Short Progressive Supranuclear Palsy Quality of Life Scale.

Movement disorders : official journal of the Movement Disorder Society·2024
Same author

Species richness and evenness of European bird communities show differentiated responses to measures of productivity.

The Journal of animal ecology·2024
Same author

Sublingual apomorphine in the treatment of Parkinson's disease.

Journal of neural transmission (Vienna, Austria : 1996)·2024

Regenerative medicine offers potential therapies for difficult-to-treat diseases like Parkinson's. Stem cell-derived dopaminergic neurons show promise for future Parkinson's disease treatments, pending further research.

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Parkinsonism, including Parkinson's disease, presents significant therapeutic challenges.
  • Current symptomatic treatments for Parkinson's disease are effective but do not halt disease progression.
  • Previous attempts at dopaminergic neuron replacement using embryonic tissue showed limited success.

Purpose of the Study:

  • To explore the potential of regenerative medicine for treating neurodegenerative diseases like Parkinson's.
  • To evaluate the feasibility of generating functional dopaminergic neurons from various stem cell sources.
  • To identify the most suitable stem cell source for initial clinical trials in Parkinson's disease.

Main Methods:

  • Investigating the generation of dopaminergic neurons from embryonic stem cells and neural stem cells.

Related Experiment Videos

Last Updated: Jul 7, 2026

Growing Neural Stem Cells from Conventional and Nonconventional Regions of the Adult Rodent Brain
11:27

Growing Neural Stem Cells from Conventional and Nonconventional Regions of the Adult Rodent Brain

Published on: November 18, 2013

  • Assessing the functional capabilities of these in-vitro generated neurons.
  • Considering pre-clinical in-vitro and in-vivo testing protocols.
  • Evaluating Good Manufacturing Production (GMP) standards for clinical translation.

    • Main Results:

    • Functional dopaminergic neurons can be generated from diverse stem cell types.
    • Stem cell-derived neurons offer a platform for extensive pre-clinical evaluation.
    • GMP-compliant production is crucial for minimizing risks in clinical applications.

    Conclusions:

    • Stem cell-based regenerative medicine holds promise for Parkinson's disease therapy.
    • Further research is needed to determine the optimal stem cell source for clinical trials.
    • Rigorous pre-clinical testing and GMP manufacturing are essential for safe and effective cell-based therapies.